[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100540505":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":12,"locations":18,"responsibleParty":36,"collaborators":7,"id":38,"slug":39,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":44,"eligibilityCriteria":45,"healthyVolunteers":40,"sex":46,"minAge":47,"maxAge":7,"enrollmentInfo":48,"targetDuration":51,"studyType":52,"phases":7,"briefSummary":53,"conditions":54,"keywords":7,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"Institut Rafael","OTHER",null,[9],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":7},"questionnaires","o Quality of life questionnaires EORTC QLQC-30 and EQ-5D-5L\n\n° questionnaires NCI- PRO-CTCAE",[13],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"Alain TOLEDANO, MD","CONTACT","+ 33 (0)1 84 00 70 07","alain.toledano@horg.fr",[19],{"facility":20,"status":21,"city":22,"state":5,"zip":23,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"Institute Rafaël","RECRUITING","Levallois-Perret","92300","France","FR",{"type":27,"coordinates":28},"Point",[29,30],2.28864,48.89389,{"lat":30,"lon":29},[33],{"name":34,"role":15,"phone":35,"phoneExt":7,"email":7},"Alain Toledano","+33 (0)1 47 58 05 96",{"type":37,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100540505","long-term-follow-up-and-quality-of-life-of-patients-treated-with-anticancer-drugs-100540505",false,"NCT06317714","Long-term Follow-up and Quality of Life of Patients Treated With Anticancer Drugs","Non-interventional and Longitudinal Study to Evaluate a List of Anticancer Drugs Under Real Conditions of Use and Measure the Quality of Life of Patients Treated at Rafaël Institute","THERAPINNOV","Inclusion Criteria:\n\n* Age equal to or greater than 18 years (adult)\n* Patients treated with an anticancer drug included in the list of innovative\u002Fexpensive therapies (protocol appendix)\n* Patients benefiting from non-pharmacological treatment at the Rafael Institute\n* Who understands the French language\n\nExclusion Criteria:\n\n* \\\u003C 18 years old\n* Patient deprived of liberty, under guardianship or unable to give consent","ALL","18 Years",{"count":49,"type":50},300,"ESTIMATED","3 Years","OBSERVATIONAL","Currently, aspects related to the effects of anticancer treatments and the quality of life of patients and their needs are still poorly documented at the Rafael Institute. Thus this study will meet a dual objective: (1) the establishment of a registry to collect data on the safety and effectiveness of innovative and expensive anticancer drugs when administered in real life and (2) a measurement quantitative quality of life of patients treated with these drugs.",[55,56,57],"Oncology","Quality of Life","Symptoms and Signs","2024-09-30",{"date":60,"type":61},"2024-10-01","ACTUAL",{"date":63,"type":61},"2024-03-08",{"date":65,"type":50},"2027-03-08",{"name":5,"class":6},1]